Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?
about
Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic backgroundTreatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, IndiaArsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort studyChronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort StudyDrug resistance in eukaryotic microorganisms.Antimony transport mechanisms in resistant leishmania parasites.Coinfection of Leptomonas seymouri and Leishmania donovani in Indian leishmaniasis.Chronic arsenic exposure and microbial drug resistance.Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis.Antimony resistance and environment: Elusive links to explore during Leishmania life cycle.Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race.VOSalophen: a vanadium complex with a stilbene derivative-induction of apoptosis, autophagy, and efficiency in experimental cutaneous leishmaniasis.Alice in microbes' land: adaptations and counter-adaptations of vector-borne parasitic protozoa and their hosts.A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis.Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach.Biophysical and Pharmacological Characterization of Energy-Dependent Efflux of Sb in Laboratory-Selected Resistant Strains of Leishmania (Viannia) Subgenus.Drug resistance and treatment failure in leishmaniasis: A 21st century challenge.Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation.Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.Characterisation of a Putative Glutamate 5- Kinase from Leishmania donovani.
P2860
Q28481297-C99A3C29-7DBA-4D56-B773-EA8C955715AFQ28484459-B1D0FDD6-4B3B-4D61-927E-DF901B075C99Q28543757-509D3BD3-9ACF-4D63-B812-5B2752C79C6BQ28552931-8124EEB7-89F7-4EF7-977C-78DE5F250144Q30248243-492F54AA-1FD6-407C-988D-4DE43F8CE29CQ33659312-756F79F1-3F20-4F19-92F5-CA84E4F2828BQ36171468-FFC74B95-7A13-4936-82D8-C9EE4A54515AQ37377400-E7F53F60-88F8-4865-BD15-DE52A8DC6ED4Q37377483-FB79BED9-F920-4EC8-97E2-2B4BC5B5D715Q37390629-14A26121-D65B-4DF3-9F9A-9CB6762A5FA4Q38118386-6EE84524-F6EB-4DFB-8BC9-9892EDD9677BQ38735051-BEAD87F8-5157-4243-8CF0-A6ED3FA933E1Q38892717-E4ED4F04-7053-4225-8D5C-3ED23DFFBD2DQ39412297-16CFD367-B090-455B-94D5-C0AC7B9F6BD9Q41034709-88C3E282-333C-4BA1-949D-D6706EC68DA0Q42149764-12F88365-CDEF-48B4-A591-E80C2C1F8D51Q46380663-CB128C61-0E77-4B78-B0E3-81060EAD58BFQ46581744-7CF10497-6523-4B8C-A7F1-3C10DE9AC127Q52579703-7FD5E523-4D70-4950-9283-096AD1767A76Q54108724-D856EEB7-C79F-42FA-82F9-4D5C61363259
P2860
Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Visceral leishmaniasis and ars ...... re in the Indian subcontinent?
@ast
Visceral leishmaniasis and ars ...... re in the Indian subcontinent?
@en
Visceral leishmaniasis and ars ...... re in the Indian subcontinent?
@nl
type
label
Visceral leishmaniasis and ars ...... re in the Indian subcontinent?
@ast
Visceral leishmaniasis and ars ...... re in the Indian subcontinent?
@en
Visceral leishmaniasis and ars ...... re in the Indian subcontinent?
@nl
prefLabel
Visceral leishmaniasis and ars ...... re in the Indian subcontinent?
@ast
Visceral leishmaniasis and ars ...... re in the Indian subcontinent?
@en
Visceral leishmaniasis and ars ...... re in the Indian subcontinent?
@nl
P2860
P50
P1476
Visceral leishmaniasis and ars ...... re in the Indian subcontinent?
@en
P2093
Meghan R Perry
P2860
P356
10.1371/JOURNAL.PNTD.0001227
P407
P577
2011-09-27T00:00:00Z